Next-Generation Sequencing (NGS) Market Projection By Top Key Players, Technology, Production Capacity, Ex-Factory Price, Revenue Analysis Forecast 2028

Share on facebook
Share on twitter
Share on linkedin

A new market study, titled “Next-Generation Sequencing (NGS) Market Forecast 2021-2028” has been featured on Fortune Business Insights™.


***Get Latest Updated Market Research Report with Free Sample Report

Market Overview:

The global next-generation sequencing market size is expected to gain momentum by reaching USD 31,411.3 million by 2026 while exhibiting a CAGR of 22.2% between 2019 to 2026. In its report titled “Next Generation Sequencing Market, 2019-2026.”, Fortune Business Insight mentions that the market stood at USD 6,335.2 million in 2018. The rising demand for cost-effective and accurate DNA sequencing to treat genetic diseases is expected to drive the market. Moreover, the launch of several genomic projects in countries such as Qatar and the U.K with able support from the government is expected to fuel the market in upcoming years.

Request for Free Sample Report PDF @

COVID-19 Impact:


The negative effect of the global pandemic, COVID-19, has been felt across several economies facing unprecedented loss. Owing to the lockdown announced by the government agencies, several research labs were shut. However, a collective effort from the government and the research labs working on the virus, pharmaceutical, and healthcare units are likely to increase the demand and aid in the resumption of sequencing tools and technology.


Market Segmentation:

Based on product type, the global market for next-generation sequencing is divided into instrument & software, consumables, and services. On the basis of application, the market is divided into diagnostics and research. By its end-user, the market is divided into research institutes, healthcare facilities, diagnostic centers, pharmaceutical and biotechnological companies, and contract research organizations. Finally, based on region, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

What does the Report Provide?


The global market for next-generation sequencing report provides a detailed analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will further contribute to the market growth.


Driving Factors


Growing Focus on Diagnosis of Diseases Globally to Augment Growth


Lower costs of sequencing solutions have resulted in the high demand for the diagnosis of several diseases. For instance, as per a new scientific paper published in the European Journal of Human Genetics, around 300 million people globally suffer from a rare genetic disease. Companies are focusing on the introduction of various test kits such as genetic testing, prenatal testing, and cancer diagnosis. For instance, in May 2018, the Centers for Medicare & Medicaid Services (CMS) declared the National Coverage Determination to perform an NSG test to diagnose cancer. In addition, government reimbursement programs for diagnostic tests and approval of several NSG tools is expected to boost the global next-generation sequencing market growth during the forecast period.


Regional Insights


North America to Remain Dominant; Presence of Major Biotech Companies to Aid Growth


North America is expected to hold the largest global next-generation sequencing market share during the forecast period. This is ascribable to factors such as the presence of supportive government policies and presence of major biotech companies and research labs. Moreover, the growing incidence of chronic disease is expected to boost the demand for the product in the region. For instance, In September 2018, the FDA approved marketing for ClonoSEQ assay, a NSG diagnostic test for the minimal residual disease (MRD), in patients suffering from acute lymphoblastic leukemia (ALL) or multiple myeloma. North America stood at USD 3.82 billion in 2020.


Asia Pacific is anticipated to hold a significant market share owing to the increasing awareness regarding well-being of reproductive health that will favor the adoption of the next-generation sequencing solutions in the region.


Competitive Landscape

Key Players to Focus on Establishing Partnerships to Intensify Competition

The market is consolidated by the presence of major companies that are striving to maintain their position by focusing on acquisitions and establishing partnerships. For instance, in June 2019, Saphetor partnered with Swift Biosciences Inc. to speed up and standardize data interpretation solutions for targeted next-generation sequencing panels. Moreover, other key players are adopting proactive strategies such as new product launches, mergers, and facility expansion to favor the market’s growth in the forthcoming years.


Industry Developments

January 2019:  PierianDx announced its partnership with Illumina to come up with informatics services such as oncology products for Illumina to support cancer diagnosis and research.


Ask For Customization @


List of the Key Players Profiled in the Global Market for Next-Generation Sequencing:

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • BGI
  • PerkinElmer Inc.
  • Eurofins Scientific
  • Macrogen, Inc.
  • PierianDx


Related Article @


NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245








Call of Duty League secures much-anticipated 12th team

Published by Inven Global The Call of Duty League (CDL) has finally secured a 12th team for next season, following the merging of OpTic Chicago with Dallas Empire earlier this year to create OpTic Texas, which left the league with only 11 teams. Oxygen Esports LLC and Boston Uprising LLC announced their plan to combine

Read More »

Main events scheduled for Wednesday, Dec. 22

Published by Kyodo News Main events scheduled in Japan for Wednesday, Dec. 22: — Bank of Japan to release minutes of Oct. 27-28 Policy Board meeting at 8:50 a.m. — Gov’t panel on imperial succession to meet and likely draw final report on measures to preserve Japan’s royal family.

Read More »

Global United States Food Waste Composting Machine Market 2021 Report provides a detailed evaluation of the market for the forecast period (2021–2027). The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics, involves the drivers, restraints, opportunities

Read More »

Baseball: Ex-Hiroshima manager Koba dies at 85

Published by Kyodo News Former Hiroshima Carp manager Takeshi Koba, who skippered the Central League club to its first four pennants and three Japan Series titles, has died, his family said through the team Tuesday. He was 85. Koba, who died from an undisclosed condition Friday, took the reins in Hiroshima early in the 1975

Read More »

Digital Patient Monitoring Devices market was valued at 2013.37 Million USD in 2020 and will grow with a CAGR of 2.35% from 2020 to 2027

The Global Digital Patient Monitoring Devices market was valued at 2013.37 Million USD in 2020 and will grow with a CAGR of 2.35% from 2020 to 2027 Global Digital Patient Monitoring Devices Market Report is segmented by, trends, latest analytics, top players, application usage, and various important geographical dividends. Digital Patient Monitoring Devices market characteristics such

Read More »

Software and IT Service Key Trends and Opportunities to 2027 Market Size and Development Trends Analysis 2021: Growth Revenue, Share and Latest Innovations, Global Opportunities and Strategic Movement by Players, Forecast to 2027

Published by Newstrail Global “Software and IT Service Key Trends and Opportunities to 2027 Market” 2021 Research Report encircles certain principal factors to guide stakeholders in recognizing the proceeding factors in the market. The study aims to provide specific factual data to help businesses figure the upcoming opportunities, competitors, motives, and overall scope. This documented

Read More »